STAAR Surgical Co Deferred Revenue
STAAR Surgical Co (STAA) had Deferred Revenue of $0 as of 2026-01-02, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-03-03
- 2026-01-02: Deferred Revenue $0.00.
- 2024-12-27: Deferred Revenue $0.00.
- 2023-12-29: Deferred Revenue $0.00.
| Period end | Deferred Revenue |
|---|---|
| 2026-01-02 | $0.00 10-K · filed 2026-03-03 |
| 2024-12-27 | $0.00 10-K · filed 2026-03-03 |
| 2023-12-29 | $0.00 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |